Merkzettel Warenkorb
  • Produktbild: Triggering of Acute Coronary Syndromes
  • Produktbild: Triggering of Acute Coronary Syndromes
Band 170

Triggering of Acute Coronary Syndromes Implications for Prevention

Aus der Reihe Developments in Cardiovascular Medicine

187,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Lieferung nach Hause

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

30.11.1995

Abbildungen

65 schwarzweisse Abbildungen, 20 Tabellen, 6 Abbildungenton-Abb., 59 schwarzweisse Zeichnungen 240 mm

Herausgeber

S.N. Willich + weitere

Verlag

Springer Netherland

Seitenzahl

430

Maße (L/B/H)

24,1/16/2,9 cm

Gewicht

807 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-0-7923-3605-1

Beschreibung

Rezension

`
... concise and well written. References are up-to-date. ... can be recommended to all clinicians involved in the care of the acute coronary patient.
'

Cardiologie, 3 (1996)

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

30.11.1995

Abbildungen

65 schwarzweisse Abbildungen, 20 Tabellen, 6 Abbildungenton-Abb., 59 schwarzweisse Zeichnungen 240 mm

Herausgeber

Verlag

Springer Netherland

Seitenzahl

430

Maße (L/B/H)

24,1/16/2,9 cm

Gewicht

807 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-0-7923-3605-1

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Triggering of Acute Coronary Syndromes
  • Produktbild: Triggering of Acute Coronary Syndromes
  • Foreword; E. Braunwald. Introduction; S.N. Willich, J.E. Muller. Part one: Epidemiology. Magnitude of cardiovascular disease: impact and prevention in populations; D.E. Bild, L. Friedman. Secular trends and declining mortality rates from coronary heart disease in the United States; R.J. Goldberg. Circadian variation in the incidence of transient myocardial ischemia; D. Mulcahy, H. Purcell. Circadian variation in the onset of myocardial infarction and sudden cardiac death; J.E. Muller, S.N. Willich. Triggering of myocardial infarction by physical activity, emotional stress and sexual activity; M.A. Mittelman. Physical activity, time of awakening, and other possible triggers of sudden cardiac death; S.N. Willich, et al. Subacute psychobiological factors predisposing to triggering of coronary syndromes; S. Wassertheil-Smoller. Part two: Physiology. The genetic contribution to the onset of acute coronary heart disease; F. Cambien, et al. Hemostatic risk factors for cardiovascular disease; P.P. Jadhav, G.H. Tofler. The imbalance of coagulation and fibrinolysis in coronary heart disease and its known risk factors; K. Winther, et al. Mechanisms contributing to the abrupt conversion from stable to unstable angina and myocardial infarction; J.T. Willerson. Circadian fluctuation of fibrinolytic factors in blood. Investigation, importance and clinical consequences; F. Andreotti, A. Manzoli. The role of thrombosis in acute coronary heart disease; A. Fernández-Ortiz, V. Fuster. The role of coronary vasomotor tone in coronary artery disease; A.A. Quyyumi. Part three: Pathology. Models of the intracoronary pathogenesis of acute coronary heart disease; J.P. Liang, et al. Some thoughts on the causes ofcoronary thrombosis in atherosclerotic arteries and on the research necessary for their future exploration; P. Constantinides. Determinants of rupture of atherosclerotic coronary lesions; P.R. Moreno, et al. Part four: Prevention. Primary prevention of triggering of coronary heart disease; I.S. Ockene. Chronopharmacological aspects of coronary heart disease; B. Lemmer, K. Witte. Prehospital care of acute coronary heart disease; H.-R. Arntz, et al. Pharmacological and invasive therapy for acute myocardial infarction; R. Schröder. The role of electrophysiology and pharmacotherapy in prevention of factors triggering sudden cardiac death; R. Haberl, et al. Secondary prevention of myocardial infarction; the roles of &bgr;-adrenergic blockers, calcium-channel blockers, angiotensin converting enzyme inhibitors, and aspirin; W.H. Frishman. Gene therapy for the vulnerable atherosclerotic plaque; L.J. Feldman, J.M. Isner. Index.